An Evidence-Aware Framework for EEG Microstate Analysis: Improved Sensitivity to Alzheimer's Disease and Ageing
Abstract
Electroencephalography (EEG) microstate analysis commonly converts each scalp topography into a winner-take-all hard label and summarises the resulting sequence using duration, occurrence, coverage, transitions, and symbolic complexity. Although interpretable, this readout discards evidence strength, assignment ambiguity, and low-confidence periods. We introduce a template evidence trajectory framework that retains, at each sampled Global Field Power (GFP) peak, the evidence for all templates or subject-specific topographic communities. Conventional hard labels are treated as a compressed readout of this multivariate trajectory. We derive two evidence-aware extensions of classical descriptors: high-evidence episode duration and episode rate, which quantify temporal clustering and fragmentation of strong state evidence, and null-state Lempel-Ziv complexity (LZC), which explicitly encodes insufficient-evidence periods. We evaluated the framework across four resting-state EEG datasets spanning Alzheimer's disease and age-related variation. Fixed-state models included K-means, AAHC, and HMMs at K = 4 and K = 7, together with adaptive subject-specific Leiden and Infomap communities. Across 32 dataset-model cases, trajectory-derived duration effects exceeded matched hard-label effects in all cases at the representative setting and in 30-32 cases across a broader parameter grid. Null-state LZC improved over traditional LZC in most cases, while classification showed modest but consistent gains for trajectory or combined features. Retaining template evidence therefore provides a more sensitive readout of EEG topographic state dynamics while remaining compatible with conventional microstate analysis.
Related
- Skull Bone Marrow as a Cranial Neuroimmune Reservoir in Alzheimer’s Disease: Amyloid, Osteoimmune Remodeling, and Translational Imaging Evidence
- Integrating Multisource Target Evidence with Machine-Learning Potency Prediction for Alzheimer's Disease Drug Discovery
- Microbiota-derived metabolite signatures in Alzheimer’s disease across the cognitive aging continuum: a human-focused systematic review and evidence-weighted knowledge graph
- An ensemble framework for robust drug response prediction and large-scale sensitivity profiling across cancers
- Anterior temporal lobes show route-dependent sensitivity to conceptual specificity: Evidence from MEG and EEG
BibTeX
@misc{wu2026evidenceaware,
title = {{An Evidence-Aware Framework for EEG Microstate Analysis: Improved Sensitivity to Alzheimer's Disease and Ageing}},
author = {Kaidong Wu and Haili Ye and Ptolemaios G Sarrigiannis and Daniel J Blackburn and Fei He},
howpublished = {arXiv},
year = {2026},
month = sep,
doi = {10.48550/arxiv.2609.08500},
eprint = {2609.08500},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2609.08500},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - An Evidence-Aware Framework for EEG Microstate Analysis: Improved Sensitivity to Alzheimer's Disease and Ageing
AU - Kaidong Wu
AU - Haili Ye
AU - Ptolemaios G Sarrigiannis
AU - Daniel J Blackburn
AU - Fei He
PY - 2026
DA - 2026/09/08
PB - arXiv
DO - 10.48550/arxiv.2609.08500
UR - https://arxiv.org/abs/2609.08500
AB - Electroencephalography (EEG) microstate analysis commonly converts each scalp topography into a winner-take-all hard label and summarises the resulting sequence using duration, occurrence, coverage, transitions, and symbolic complexity. Although interpretable, this readout discards evidence strength, assignment ambiguity, and low-confidence periods. We introduce a template evidence trajectory framework that retains, at each sampled Global Field Power (GFP) peak, the evidence for all templates or subject-specific topographic communities. Conventional hard labels are treated as a compressed readout of this multivariate trajectory. We derive two evidence-aware extensions of classical descriptors: high-evidence episode duration and episode rate, which quantify temporal clustering and fragmentation of strong state evidence, and null-state Lempel-Ziv complexity (LZC), which explicitly encodes insufficient-evidence periods. We evaluated the framework across four resting-state EEG datasets spanning Alzheimer's disease and age-related variation. Fixed-state models included K-means, AAHC, and HMMs at K = 4 and K = 7, together with adaptive subject-specific Leiden and Infomap communities. Across 32 dataset-model cases, trajectory-derived duration effects exceeded matched hard-label effects in all cases at the representative setting and in 30-32 cases across a broader parameter grid. Null-state LZC improved over traditional LZC in most cases, while classification showed modest but consistent gains for trajectory or combined features. Retaining template evidence therefore provides a more sensitive readout of EEG topographic state dynamics while remaining compatible with conventional microstate analysis.
ER -